drugset / Trial / NCT01830764

Open-label Safety and Tolerability Study of LTS-PDT in Healthy Volunteers

NCT01830764 ↗

Phase 1 Completed 12 enrolled Dermira, Inc.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is assess the safety and tolerability of lemuteporfin topical solution (LTS) with exposure to red light (PDT), when applied to the backs of healthy volunteers.

Timeline

Start
2013-04
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Lemuteporfin Small molecule 0.3 % Topical

Indications